Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2005, p. 2429-2437, Vol. 49, No. 6
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.6.2429-2437.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages
Jean-Michel Michot,
Cristina Seral,
,
Françoise Van Bambeke,
Marie-Paule Mingeot-Leclercq, and
Paul M. Tulkens*
Unité de Pharmacologie Cellulaire et Moléculaire, Université catholique de Louvain, Brussels, Belgium
Received 11 September 2004/
Returned for modification 22 December 2004/
Accepted 31 January 2005
Ciprofloxacin is subject to efflux from J774 macrophages through a multidrug resistance-related protein-like transporter (J. M. Michot, F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens, Antimicrob. Agents Chemother. 48:2673-2682, 2004). Here, we compare ciprofloxacin to levofloxacin, garenoxacin, and moxifloxacin for transport. At 4 mg/liter, an apparent steady state in accumulation was reached after 30 to 60 min for all quinolones but to quite different levels (approximately 3, 5, 10, and 16 fold). Accumulation of ciprofloxacin was increased (to about 16 to 20 fold) by ATP depletion, increase in extracellular concentration, and the addition of probenecid, gemfibrozil, or MK571 (but not verapamil or GF120918). These treatments did not affect the accumulation of moxifloxacin. Levofloxacin and garenoxacin showed an intermediate behavior. Efflux of ciprofloxacin was slowed down by probenecid (half-life, 7.2 versus 1.6 min). Moxifloxacin efflux was faster and unaffected by probenecid (half-lifes, 0.27 versus 0.33 min). Efflux of levofloxacin and garenoxacin was modestly decreased by probenecid (1.5 and 2.1 fold). Accumulation of 14C-labeled ciprofloxacin was increased by unlabeled ciprofloxacin and moxifloxacin, but moxifloxacin was two times less potent. Accumulation of moxifloxacin at 4°C was almost identical to that at 37°C, whereas that of ciprofloxacin was minimal (levofloxacin and garenoxacin showed intermediate behaviors). Cells subjected to thermal shock (56°C; 10 min) accumulated all quinolones at a similar level (16 to 23 fold). We conclude that moxifloxacin is apparently not subject to efflux from J774 macrophages, even though it can interact with the ciprofloxacin transporter. Levofloxacin and garenoxacin are partially effluxed. Data suggest that efflux plays an important role in the differential accumulation of quinolones by J774 macrophages.
* Corresponding author. Mailing address: Unité de Pharmacologie Cellulaire et Moléculaire, Université catholique de Louvain, UCL 73.70 avenue E. Mounier 73, B-1200 Brussels, Belgium. Phone: 32-2-764 73 70. Fax: 32-2-764 73 73. E-mail: tulkens{at}facm.ucl.ac.be.
These two authors contributed equally to this work.
Present address: Department of Clinical Microbiology, University Hospital "Lozano Blesa," Zaragoza, Spain.
Antimicrobial Agents and Chemotherapy, June 2005, p. 2429-2437, Vol. 49, No. 6
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.6.2429-2437.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Marquez, B., Caceres, N. E., Mingeot-Leclercq, M.-P., Tulkens, P. M., Van Bambeke, F.
(2009). Identification of the Efflux Transporter of the Fluoroquinolone Antibiotic Ciprofloxacin in Murine Macrophages: Studies with Ciprofloxacin-Resistant Cells. Antimicrob. Agents Chemother.
53: 2410-2416
[Abstract]
[Full Text]
-
Brillault, J., De Castro, W. V., Harnois, T., Kitzis, A., Olivier, J.-C., Couet, W.
(2009). P-Glycoprotein-Mediated Transport of Moxifloxacin in a Calu-3 Lung Epithelial Cell Model. Antimicrob. Agents Chemother.
53: 1457-1462
[Abstract]
[Full Text]
-
Stergiopoulou, T., Meletiadis, J., Sein, T., Papaioannidou, P., Tsiouris, I., Roilides, E., Walsh, T. J.
(2009). Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. J Antimicrob Chemother
63: 343-348
[Abstract]
[Full Text]
-
Van de Velde, S., Nguyen, H. A., Van Bambeke, F., Tulkens, P. M., Grellet, J., Dubois, V., Quentin, C., Saux, M.-C.
(2008). Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes. J Antimicrob Chemother
62: 518-521
[Abstract]
[Full Text]
-
Lismond, A., Tulkens, P. M., Mingeot-Leclercq, M.-P., Courvalin, P., Van Bambeke, F.
(2008). Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected with Listeria monocytogenes: Studies with Ciprofloxacin and Moxifloxacin. Antimicrob. Agents Chemother.
52: 3040-3046
[Abstract]
[Full Text]
-
Grayo, S., Lott-Desroches, M.-C., Dussurget, O., Respaud, R., Fontanet, A., Join-Lambert, O., Singlas, E., Le Monnier, A.
(2008). Rapid Eradication of Listeria monocytogenes by Moxifloxacin in a Murine Model of Central Nervous System Listeriosis. Antimicrob. Agents Chemother.
52: 3210-3215
[Abstract]
[Full Text]
-
Grayo, S., Join-Lambert, O., Desroches, M. C., Le Monnier, A.
(2008). Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenes. Antimicrob. Agents Chemother.
52: 1697-1702
[Abstract]
[Full Text]
-
Michot, J.-M., Heremans, M. F., Caceres, N. E., Mingeot-Leclercq, M.-P., Tulkens, P. M., Van Bambeke, F.
(2006). Cellular accumulation and activity of quinolones in ciprofloxacin-resistant j774 macrophages.. Antimicrob. Agents Chemother.
50: 1689-1695
[Abstract]
[Full Text]
-
Barcia-Macay, M., Seral, C., Mingeot-Leclercq, M.-P., Tulkens, P. M., Van Bambeke, F.
(2006). Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages. Antimicrob. Agents Chemother.
50: 841-851
[Abstract]
[Full Text]